Filing Details

Accession Number:
0001209191-23-049314
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-13 17:33:22
Reporting Period:
2023-09-11
Accepted Time:
2023-09-13 17:33:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1828673 Hcw Biologics Inc. HCWB Pharmaceutical Preparations (2834) 825024477
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1866256 Rebecca Byam C/O Hcw Biologics Inc
2929 N. Commerce Parkway
Miramar FL 33025
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-11 5,000 $2.05 563,946 No 4 P Direct
Common Stock Acquisiton 2023-09-12 5,000 $2.09 568,946 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The range of prices for the shares of Common Stock is from $2.01 to $2.09. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
  2. The range of prices for the shares of Common Stock is from $2.07 to $2.10. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.